FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb's ...
Medscape5 天
Take Steps to Avoid Inadvertent IV Administration of Nimodipine
it is critical that pharmacy communicate the potential danger of inadvertent IV injection directly to the person responsible for administering the drug. A reminder in the computer and on the drug ...
Jeremiah White IV’s path to pro soccer mirrors that of his father. But his goals are ...
When Jeremiah White IV turned 11, he went to his dad and asked him to train him in soccer. He knew his dad, Jeremiah White III, a high school and college All-American who played professionally in ...
The American Journal of Managed Care5 天
First Subcutaneous Prophylaxis for Hemophilia A and B With Inhibitors Approved by FDA
The approval of concizumab-mtci (Alhemo) injection marks a significant milestone in managing hemophilia A and B with ...
oncnursingnews5 天
EGFR-Targeted Therapies in NSCLC: IV vs Subcutaneous Administration
Panelists discuss how amivantamab’s dual targeting of EGFR and MET may address resistance mechanisms and unmet needs in ...
NASA’s Parker Solar Probe aims to fly closer to the sun like never before
A NASA spacecraft is about to make the closest approach to the sun. The Parker Solar Probe was launched in 2018 to get a ...
Takeaways from AP’s report on social safety nets in states that ban abortion
Recent research and an analysis by The Associated Press found states with restrictive abortion laws have more porous safety ...
Cure Today1 天
Subcutaneous Opdivo Receives FDA Approval for Advanced, Metastatic Solid Tumors
Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...
Managed Healthcare Executive4 小时
FDA Approves Subcutaneous Opdivo to Treat Solid Tumors
Opdivo Qvantig is the first subcutaneously administered PD-1 inhibitor approved by the FDA. It is expected to be available in ...
Nasal solution used in hospitals recalled due to ‘the potential for administration errors’
The product was never submitted for approval by the FDA and is an unapproved drug for which safety and efficacy have not been ...
WLKY4 天
Research study at UofL first in US to treat heart failure with umbilical cord stem cells
This study is the first to inject repeated doses of stem cells intravenously into patients who have heart failure due to a heart attack or coronary artery disease.